Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Levodopa
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Inbrija 33mg inhalation powder capsules with device
0409010I0BBAAAN
|
Inbrija | Levodopa | Central Nervous System | No data available |
|
Levodopa 100mg/5ml oral liquid
0409010I0AAAKAK
|
Levodopa | Levodopa | Central Nervous System | No data available |
|
Levodopa 125mg/5ml oral suspension
0409010I0AAAJAJ
|
Levodopa | Levodopa | Central Nervous System | No data available |
|
Levodopa 25mg/5ml oral suspension
0409010I0AAAMAM
|
Levodopa | Levodopa | Central Nervous System | No data available |
|
Levodopa 33mg inhalation powder capsules with device
0409010I0AAANAN
|
Levodopa | Levodopa | Central Nervous System | No data available |
|
Levodopa 500mg tablets
0409010I0AAAFAF
|
Levodopa | Levodopa | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.